Nasdaq smmt.

Menlo Park, California, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that it is nearing the previously-announced ...Summit Therapeutics Inc (NASDAQ:SMMT) shares are down by almost 13% year to date bringing their 12-month return to over 85%. As of this writing, Summit Therapeutics shares are trading at around $3.70 with a 52-week range of $0.66 to $5.78, giving the company a market capitalization of more than $835 million. PDS …Webhá 5 dias ... Find the latest dividend history for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.OXFORD, United Kingdom, April 26, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Dec 4, 2023 · Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ...

Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research ...WebJun 22, 2022 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Dec 1, 2023 · During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.99 million, with the beta value of the company hitting -1.00. At the end of the trading day, the stock’s price was $2.03, reflecting an intraday gain of 4.10% or $0.08. The 52-week high for the SMMT share is $5 ... OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ...

Nov 25, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting -1.00. At the close of trading, the stock’s price was $2.00, to imply an increase of 2.56% or $0.05 in intraday trading. The SMMT share’s 52-week high ... há 10 horas ... Price Performance Review of SMMT. On Friday, Summit Therapeutics Inc [NASDAQ:SMMT] saw its stock jump 4.93% to $2.13. On the same session, the ...MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...WebOxford, UK, and Cambridge, MA, US, 14 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today announces two presentations ...

há 5 dias ... Summit Therapeutics Inc (NASDAQ:SMMT) cash flow statement.

Principal Financial Group Inc. purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) during the second quarter, according …

Summit Therapeutics (NASDAQ: SMMT) does not pay a dividend. Does Summit Therapeutics have sufficient earnings to cover their dividend?Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ...OXFORD, United Kingdom, March 07, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces it has opened enrolment in a planned additional group in its Phase 2 open ...Based on analysts offering 12 month price targets for SMMT in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Cambridge, MA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced topline results for the Phase III Ri-CoDIFy study ...WebPhunware Inc (NASDAQ:PHUN) has a beta value of 10.36 and has seen 4.58 million shares traded in the recent trading session. The company, currently valued at $19.34M, closed the recent trade at $0.14 per share which meant it gained $0.01 on the day or 13.69% during that session. The PHUN stock price ...Web

Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on ...OXFORD, United Kingdom, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and ...Hedge fund interest in Summit Therapeutics PLC (NASDAQ:SMMT) shares was flat at the end of last quarter. This is usually a negative indicator. This is usually a negative indicator.Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ...Avenue Therapeutics Inc (NASDAQ:ATXI)’s Major holders. Insiders own 18.50% of the company shares, while shares held by institutions stand at 9.14% with a share float percentage of 11.21%. Investors are also buoyed by the number of investors in a company, with Avenue Therapeutics Inc having a total of 17 institutions that hold shares …Web

Phunware Inc (NASDAQ:PHUN)’s Major holders Insiders own 8.46% of the company shares, while shares held by institutions stand at 9.60% with a share float percentage of 10.48%. Investors are also buoyed by the number of investors in a company, with Phunware Inc having a total of 43 institutions that hold shares in the company.

Summit Therapeutics Inc. (NASDAQ:SMMT) insiders placed bullish bets worth US$62m in the last 12 months. (Simply Wall St.) Mar-17-22 04:14PM. Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021. (GlobeNewswire) +7.93%.Find the latest Insider Activity data for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.Oct 26, 2023 · MENLO PARK, Calif., October 26, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its third quarter 2023 financial results and ... Nov 28, 2023 · Stock analysis for Summit Therapeutics Inc (SMMT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Follow. Cambridge, MA, May 18, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today that it has selected a new preclinical candidate, SMT026738 (“SMT-738”), for development in the ...Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 3.00% Before Hours... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...Web

Follow. Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the successful closing of its ...

Oxford, UK, and Cambridge, MA, US, 27 March 2019 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today reports its financial results for the ...

OXFORD, UK, Jan. 21, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (LSE:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ...Nov 30, 2023 · The stock price of Summit Therapeutics Inc (NASDAQ: SMMT) has surged by 3.33 when compared to previous closing price of 1.95, but the company has seen a 3.33% gain in its stock price over the last five trading sessions. Seeking Alpha reported 2023-09-26 that Summit Therapeutics Inc., backed by biotech billionaire Bob Duggan, has transitioned […] 3 de nov. de 2023 ... (NASDAQ: SMMT) (“Summit”) will present data for the novel, potential first-in-class investigational bispecific antibody, ivonescimab (AK112 ...Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts.WebShares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report) were down 3.9% on Friday .The company traded as low as $1.94 and last traded at …Dec 4, 2023 · Avenue Therapeutics Inc (NASDAQ:ATXI)’s Major holders. Insiders own 18.50% of the company shares, while shares held by institutions stand at 9.14% with a share float percentage of 11.21%. Investors are also buoyed by the number of investors in a company, with Avenue Therapeutics Inc having a total of 17 institutions that hold shares in the ... Oxford, UK, and Cambridge, MA, US, August 19, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that at a Court convened meeting of shareholders and at a general meeting of ...For the three months ended September 30th, 2018 vs September 30th, 2017, Global Payments reported revenue of $857.67MM vs $1,038.91MM (down 17.44%) and analysts estimated basic earnings per share ...WebSummit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...OXFORD, United Kingdom, March 07, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...Web

Summit Therapeutics Inc. Common Stock (SMMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ... Investors eyeing a purchase of Summit Therapeutics Inc (Symbol: SMMT) stock, but cautious about paying the going market price of $2.52/share, might benefit from considering selling puts among the ...Instagram:https://instagram. option trading best platformjaime perezinvesco developing marketsbest way to invest 2000 Oxford, UK, and Cambridge, MA, US, 14 April 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr Robert (Bob) Duggan has been appointed Chief Executive Officer (‘CEO’) of ...The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97. crown dental insurancebest dividend stocks australia Should You Buy or Sell Summit Therapeutics Stock? Get The Latest SMMT Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at ...78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ... namibian stock exchange prices Summit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ...